Exclusive

Publication

Byline

Location

US Patent Issued to Universal Display on Aug. 25 for "Organic electroluminescent materials and devices" (New Jersey Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,874, issued on Aug. 25, was assigned to Universal Display Corp. (Ewing, N.J.). "Organic electroluminescent materials and devices" was inven... Read More


US Patent Issued to Dart NeuroScience on Aug. 25 for "Substituted pyrazolopyrimidinone compounds as PDE2 inhibitors" (California Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,875, issued on Aug. 25, was assigned to Dart NeuroScience LLC (Dallas). "Substituted pyrazolopyrimidinone compounds as PDE2 inhibitors" was... Read More


US Patent Issued to SCHRODINGER on Aug. 25 for "Cyclic compounds and methods of using same" (California, New Jersey, New York, Oregon Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,876, issued on Aug. 25, was assigned to SCHRODINGER INC. (New York). "Cyclic compounds and methods of using same" was invented by Sayan Mon... Read More


US Patent Issued to Kymera Therapeutics on Aug. 25 for "Protein degraders and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,877, issued on Aug. 25, was assigned to Kymera Therapeutics Inc. (Watertown, Mass.). "Protein degraders and uses thereof" was invented by N... Read More


US Patent Issued to Janssen Pharmaceutica on Aug. 25 for "Tricyclic pyrimidines as cyclin-dependent kinase 7 (CDK7) inhibitors" (French, American Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,878, issued on Aug. 25, was assigned to Janssen Pharmaceutica NV (Beerse, Belgium). "Tricyclic pyrimidines as cyclin-dependent kinase 7 (CD... Read More


US Patent Issued to VANDERBILT UNIVERSITY on Aug. 25 for "Quinazoline-4(3H)-one derivatives as negative allosteric modulators of metabotropic glutamate receptor 2" (Tennessee Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,879, issued on Aug. 25, was assigned to VANDERBILT UNIVERSITY (Nashville, Tenn.). "Quinazoline-4(3H)-one derivatives as negative allosteric... Read More


US Patent Issued to ITEOS BELGIUM on Aug. 25 for "Macrocyclic diamine derivatives as ENT inhibitors for the treatment of cancers, and combination thereof with adenosine receptor antagonists" (Belgian, British, Swiss Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,880, issued on Aug. 25, was assigned to ITEOS BELGIUM SA (Gosselies, Belgium). "Macrocyclic diamine derivatives as ENT inhibitors for the t... Read More


US Patent Issued to Regeneron Pharmaceuticals on Aug. 25 for "Rifamycin analogs and antibody-drug conjugates thereof" (New York, Pennsylvania Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,881, issued on Aug. 25, was assigned to Regeneron Pharmaceuticals Inc.. "Rifamycin analogs and antibody-drug conjugates thereof" was invent... Read More


US Patent Issued on Aug. 25 for "Adduct comprising at least a metal selected from gold, silver and copper and an adduct of a carbon allotrop and a pyrrolic compound" (Italian Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,882, issued on Aug. 25. "Adduct comprising at least a metal selected from gold, silver and copper and an adduct of a carbon allotrop and a ... Read More


US Patent Issued to UMICORE on Aug. 25 for "Organometallic compounds" (British Inventor)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,883, issued on Aug. 25, was assigned to UMICORE AG & Co. KG (Hanau-Wolfgang, Germany). "Organometallic compounds" was invented by Albert Ba... Read More